Document is current
Any future updates will be listed below
-
Authors
Bayer, Thomas A. https://orcid.org/0000-0003-1616-0714
Liu, Yanchen https://orcid.org/0009-0006-4471-1420
Vishnepolskiy, Igor https://orcid.org/0009-0001-3623-324X
Baez, Day https://orcid.org/0009-0005-3997-5926
Sanders, Lisbeth https://orcid.org/0009-0006-7794-4247
Williams, Rebecca https://orcid.org/0009-0000-3766-4298
Sanders, Jeff https://orcid.org/0009-0001-8742-7124
Serpico, Anthony https://orcid.org/0009-0007-6915-7005
Gravenstein, Stefan https://orcid.org/0000-0001-6000-6859
- License Information
-
More Information
Article History
Received: 31 January 2024
Accepted: 3 July 2024
First Online: 23 September 2024
Declarations
:
: Advarra provided Institutional Review Board (IRB) approval and oversight of all study materials and procedures through a reliance agreement with the Rhode Island Hospital IRB. Advarra complies with US federal regulations and the ethical principles of the Belmont Report, the Nuremberg Code, and the Declaration of Helsinki. The Advarra IRB approved this study on August 24, 2022, protocol number Pro00062144. All participants or their legally-authorized representative provided written informed using an IRB-approved Informed Consent Form.
: Not applicable.
: Lisbeth Sanders, Lisbeth Sanders, Rebecca Williams, and Anthony Serpico have a commercial interest in the development and commercialization of the prototype that was tested in this study. The remaining authors have no competing interest.
